HT
GMAB icon

Headlands Technologies’s Genmab GMAB Stock Holding History

Headlands Technologies’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$746K Buy
27,141
+14,138
+109% +$376K 0.08% 311
2026
Q1 		$349K Buy
13,003
+5,949
+84% +$178K 0.04% 460
2025
Q4 		$217K Sell
7,054
-1,331
-16% -$41.5K 0.02% 579
2025
Q3 		$257K Sell
8,385
-1,781
-18% -$43.4K 0.02% 496
2025
Q2 		$210K Buy
10,166
+8,606
+552% +$177K 0.03% 457
2025
Q1 		$30.5K Buy
1,560
+1,464
+1,525% +$30.7K ﹤0.01% 794
2024
Q4 		$2K Buy
+96
New +$2.11K ﹤0.01% 1112
2024
Q3 		– Sell
-5,138
Closed -$129K – 1314
2024
Q2 		$129K Buy
5,138
+4,853
+1,703% +$138K 0.01% 572
2024
Q1 		$8.52K Buy
+285
New +$8.37K ﹤0.01% 1041
2023
Q4 		– Sell
-772
Closed -$27.2K – 1073
2023
Q3 		$27.2K Buy
+772
New +$29.4K 0.01% 542

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Headlands Technologies's GMAB Position: Q2 2026 in Review

Headlands Technologies increased its Genmab (GMAB) stake by 109% in Q2 2026, buying an estimated $376K and bringing the position to 27,141 shares worth $746K. The position accounts for 0.08% of the portfolio, ranked #311.

Headlands Technologies first reported a position in GMAB in Q3 2023 and has held it in 10 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Headlands Technologies held 27,141 shares of Genmab worth $746K as of Q2 2026.
  • Headlands Technologies bought 14,138 Genmab shares in Q2 2026, an estimated $376K.
  • Genmab made up 0.08% of Headlands Technologies's portfolio in Q2 2026, its #311 holding.
  • Headlands Technologies first reported a position in Genmab in Q3 2023 and has held it in 10 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.